Patents/ Technology Licensing

Treatment of Leukemia and Lymphoma with Memory CD8+ T Cell Donor Lymphocyte Infusion Therapy: Japanese patent - JP,6096677,B (issued February 24, 2017)

Enhancement of Allogeneic Hematopoietic Stem Cell Transplantation: US patent-9504715B2 (issued November 29, 2016)

Treatment of Leukemia and Lymphoma with Memory CD8⁺ T Cell Donor Lymphocyte Infusion Therapy.  (Suparna Dutt, Samuel Strober and Robert Lowsky. Patent pending European Patent Office, United Kingdom, China, Australia, Canada.  (Stanford Office of Technology Licensing Docket #10-305).

Treatment of Leukemia and Lymphoma with Memory CD8⁺ T Cell Donor Lymphocyte Infusion Therapy (Exclusive License to Medeor Therapeutics)